VNTR2/VNTR3 genotype in the FCGRT gene is associated with reduced effectiveness of intravenous immunoglobulin in patients with myasthenia gravis

BACKGROUND: Intravenous immunoglobulin (IVIG) has been commonly used to treat myasthenia gravis exacerbation, but is still ineffective in nearly 30% of patients. A variable number of tandem repeat (VNTR) polymorphism in the FCGRT gene has been found to reduce the efficiency of IgG biologics. However...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Adv Neurol Disord
Autors principals: Su, Shengyao, Liu, Qing, Zhang, Xueping, Wen, Xinmei, Lei, Lin, Shen, Faxiu, Fan, Zhirong, Duo, Jianying, Lu, Yan, Di, Li, Wang, Min, Chen, Hai, Zhu, Wenjia, Xu, Min, Wang, Suobin, Da, Yuwei
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2021
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7844454/
https://ncbi.nlm.nih.gov/pubmed/33552238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286420986747
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars